Cargando…

Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer

The molecular heterogeneity and distinct features of HER2-low breast cancers, particularly in the Chinese population, are not well understood, limiting its precise management in the era of antibody‒drug conjugates. To address this issue, we established a cohort of 434 Chinese patients with HER2-low...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Lei-Jie, Ma, Ding, Xu, Yu-Zheng, Li, Ming, Li, Yu-Wei, Xiao, Yi, Jin, Xi, Wu, Song-Yang, Zhao, Ya-Xin, Wang, Han, Yang, Wen-Tao, Jiang, Yi-Zhou, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444861/ https://www.ncbi.nlm.nih.gov/pubmed/37607916 http://dx.doi.org/10.1038/s41467-023-40715-x

Ejemplares similares

Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer
por: Dai, Lei-Jie, et al.
Publicado: (2023)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
por: Zhao, Shen, et al.
Publicado: (2019)

Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
por: Liu, Xi-Yu, et al.
Publicado: (2018)

Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
por: Yang, Liu, et al.
Publicado: (2022)

Prognostic implications of HER2 heterogeneity in gastric cancer
por: Motoshima, Shigenobu, et al.
Publicado: (2018)

Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies
por: Zhang, Cheng, et al.
Publicado: (2020)

Targeted Approaches to HER2-Low Breast Cancer: Current Practice and Future Directions
por: Lai, Heng-Zhou, et al.
Publicado: (2022)

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2015)

Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status
por: Xiao, Yi, et al.
Publicado: (2017)

Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study
por: Shen, Xia-Bo, et al.
Publicado: (2021)

Interdisciplinarity research based on NSFC-sponsored projects: A case study of mathematics in Chinese universities
por: Shao, Zhi-Yi, et al.
Publicado: (2018)

Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
por: Hu, Xi′e, et al.
Publicado: (2023)

Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
por: Yang, Hai-Yuan, et al.
Publicado: (2017)

HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
por: Fusco, Nicola, et al.
Publicado: (2016)

Clinicopathological features and prognosis of patients with HER2-low breast cancer
por: Yang, Xin, et al.
Publicado: (2023)

Breast cancer heterogeneity: mechanisms, proofs, and implications
por: Hsiao, Yi-Hsuan, et al.
Publicado: (2010)

Predicting combinative drug pairs towards realistic screening via integrating heterogeneous features
por: Shi, Jian-Yu, et al.
Publicado: (2017)

Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
por: Yang, Hai-Yuan, et al.
Publicado: (2018)

Differences in the origin of philosophy between Chinese medicine and western medicine: Exploration of the holistic advantages of Chinese medicine
por: Sun, Da-zhi, et al.
Publicado: (2013)

Genetic spectrum and clinical features in a cohort of Chinese patients with autosomal recessive cerebellar ataxias
por: Cheng, Hao-Ling, et al.
Publicado: (2021)

Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
por: Fu, Tong, et al.
Publicado: (2021)

Polymorphism rs4919510:C>G in Mature Sequence of Human MicroRNA-608 Contributes to the Risk of HER2-Positive Breast Cancer but Not Other Subtypes
por: Huang, A-Ji, et al.
Publicado: (2012)

Breast cancer screening and early diagnosis in Chinese women
por: Ding, Rui, et al.
Publicado: (2022)

Comparative mitogenome analyses uncover mitogenome features and phylogenetic implications of the subfamily Cobitinae
por: Yu, Peng, et al.
Publicado: (2021)

Measurement Properties of the Simplified Chinese Version of the Lumbar Spine Instability Questionnaire for Patients With Low Back Pain in Mainland China
por: Chen, Shao-Feng, et al.
Publicado: (2023)

The Effect of HER2 Single Nucleotide Polymorphisms on Cervical Cancer Susceptibility and Survival in a Chinese Population
por: Gao, Yan, et al.
Publicado: (2019)

Enterovirus-related diarrhoea in Guangdong, China: clinical features and implications in hand, foot and mouth disease and herpangina
por: Zhou, Hong-Tao, et al.
Publicado: (2016)

HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
por: Cai, Mengyuan, et al.
Publicado: (2023)

Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of (18)F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
por: Gong, Chengcheng, et al.
Publicado: (2022)

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
por: Chen, Mengdi, et al.
Publicado: (2022)

Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report
por: Zhang, Qi, et al.
Publicado: (2022)

Clinical characteristics and image features of pulmonary cryptococcosis: a retrospective analysis of 50 cases in a Chinese hospital
por: Lu, Yuan, et al.
Publicado: (2022)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
por: Ding, Jia-Han, et al.
Publicado: (2022)

Evaluation of Diagnostic Efficiency of Ultrasound Features on Malignant Thyroid Nodules in Chinese Patients
por: Li, Ru-Qiang, et al.
Publicado: (2016)

Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR(+)/HER2(−) breast cancer
por: Hu, Jia, et al.
Publicado: (2023)

Clinicopathological features and Borrmann classification associated with HER2-positive in primary gastric cancer
por: Dai, Xiaomin, et al.
Publicado: (2019)

HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population
por: Rong, Lulu, et al.
Publicado: (2020)

HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
por: Ocaña, Alberto, et al.
Publicado: (2020)

Modulating cancer stemness provides luminal a breast cancer cells with HER2 positive-like features
por: Mei, Yi, et al.
Publicado: (2020)

Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer patients
por: Wang, Jinhao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6jpud2pid3kctlb3vhhbg77o00